Featured
Zone 2 Training: What's Real, What's Overhyped, and What You Should Actually Do
Zone 2 training is everywhere — but what does the research actually say? An honest, evidence-based breakdown of what Zone 2 is, its real benefits, its limitations, and how to find your Zone 2 without expensive gear.
All Articles
Tirzepatide vs Semaglutide: An Honest Breakdown
Zepbound vs Wegovy — what the head-to-head trial data actually shows, who each medication is better for, side effect differences, birth control interactions, and what most patients don't know. Written by a PA-C in obesity medicine.
Read → PA-C reviewedICD-10 Coding for Obesity and GLP-1 Medications: A Provider Quick-Reference
A complete ICD-10 quick-reference for obesity medicine providers — E66 and Z68 codes, comorbidity codes for GLP-1 prescribing, FY2025 updates, common errors, and how coding affects prior authorization outcomes.
Read → PA-C reviewedZone 2 Training: What's Real, What's Overhyped, and What You Should Actually Do
Zone 2 training is everywhere — but what does the research actually say? An honest, evidence-based breakdown of what Zone 2 is, its real benefits, its limitations, and how to find your Zone 2 without expensive gear.
Read → PA-C reviewedGLP-1 Medications and Perimenopause: Weight, Hormones, and What Changes After 40
Why perimenopause makes weight loss so much harder — and how GLP-1 medications interact with your changing hormones, metabolism, muscle, and gut health. Evidence-based guidance from a PA-C in obesity medicine.
Read → PA-C reviewedIs It Postpartum Depression — or Your Thyroid?
Postpartum thyroiditis affects up to 10% of new mothers and is routinely missed. Learn about the two phases, why it's confused with postpartum depression, when to test, and what to ask your provider.
Read → PA-C reviewedCreatine: What It Actually Is, Who It's For, and What the Research Shows
An honest, research-backed look at creatine — what it does, what the evidence supports for muscle, brain, and women's health, who should be cautious, and how to choose a supplement.
Read → PA-C reviewedPCOS and Weight: What's Really Going On — and What Can Actually Help
A deep dive into PCOS — what it is, why weight management is harder with PCOS, the role of insulin resistance, and the full treatment landscape including lifestyle, metformin, and GLP-1 medications like semaglutide and tirzepatide.
Read → PA-C reviewedMuscle Loss on GLP-1 Medications: What's Real, What's Preventable
GLP-1 medications like semaglutide and tirzepatide can cause some muscle loss — but most of it is preventable. A PA-C in obesity medicine explains the data, your protein targets, and how to train smarter.
Read → PA-C reviewedPrior Authorization for GLP-1 Obesity Medications: A Provider's Guide
A step-by-step prior authorization guide for Wegovy and Zepbound — ICD-10 codes, documentation requirements, denial reasons, appeal strategies, and a letter of medical necessity template.
Read → PA-C reviewedPerimenopause & Menopause: What's Actually Happening in Your Body
The transition to menopause can span a decade — and it comes with real, measurable, and often undertreated changes. Here's what the science actually says.
Read → PA-C reviewedAlcohol and GLP-1 Medications: What You Need to Know
Can you drink alcohol on Ozempic, Wegovy, or Zepbound? A PA-C in obesity medicine explains why your tolerance may have changed, what the research says about GLP-1s and alcohol cravings, liver considerations, and practical guidance for staying safe.
Read → PA-C reviewedCompounded Semaglutide and Tirzepatide in 2026: What Providers Need to Know
A clinical reference for providers navigating compounded GLP-1 medications — FDA enforcement timeline through March 2026, safety concerns, patient transition guidance, documentation and liability considerations, and what comes next.
Read → PA-C reviewedPostpartum Weight and GLP-1s: What's Safe, What Isn't, and What to Ask
Thinking about starting a GLP-1 medication after having a baby? A PA-C in obesity medicine explains what's safe during breastfeeding, when the timing is right, what your body is doing hormonally, and how to have this conversation with your provider.
Read → PA-C reviewedManaging GLP-1 Side Effects in Clinical Practice: What Actually Works
A clinical reference for providers managing GLP-1 side effects — nausea, constipation, vomiting, GERD, fatigue, hair loss, mood changes, and serious adverse events. Includes dose escalation frameworks, patient communication language, and documentation guidance.
Read → PA-C reviewedGLP-1 Medications and Thyroid Cancer Risk: What the Evidence Actually Shows
A deep dive into the thyroid cancer boxed warning on GLP-1 medications — the difference between papillary and medullary thyroid cancer, what the human evidence actually shows, who is truly contraindicated, what calcitonin testing can tell you, and how providers should have this conversation.
Read → PA-C reviewedStopping GLP-1 Medications: What Happens to Your Weight and How to Prepare
What actually happens when you stop Ozempic, Wegovy, or Zepbound — the weight regain data, what health gains reverse, how to prepare, and how to have an honest conversation with your provider about stopping.
Read → PA-C reviewedWhen Your Body Changes, So Does Everything Else
Weight loss on GLP-1 medications changes more than your body — it changes how people treat you, how you see yourself, your relationships, your social life, and what you want. A warm, honest guide to navigating all of it.
Read → PA-C reviewedGLP-1 Plateaus: Why Weight Loss Slows and What to Do Next
Your weight has stopped moving on semaglutide or tirzepatide. A PA-C in obesity medicine explains why plateaus happen biologically, how to tell a true plateau from a slow period, and what actually helps.
Read → PA-C reviewedGLP-1 and Constipation: Why It Happens and What Actually Helps
Constipation on semaglutide or tirzepatide affects up to 1 in 4 patients. A PA-C in obesity medicine explains why it happens, the fiber-nausea trade-off, and a step-by-step management plan.
Read → PA-C reviewedCounseling Patients on GLP-1 Expectations: A Framework for the First Visit
A PA-C in obesity medicine shares the framework she uses at every first GLP-1 visit — covering expectation-setting, patient readiness, labwork, insurance basics, mental health screening, and what happens if the medication is stopped.
Read → PA-C reviewedGLP-1 Hair Loss: Is It Real, Who Gets It, and What You Can Do About It
Experiencing hair loss on semaglutide or tirzepatide? A PA-C in obesity medicine explains the real cause, who's most at risk, and what actually helps — including minoxidil, supplements, and a dose-reduction option most patients never hear about.
Read → PA-C reviewedHow Much Protein Do You Really Need on a GLP-1?
The standard protein recommendation isn't enough on semaglutide or tirzepatide. A PA-C in obesity medicine breaks down exactly how much you need, why, and how to hit your target when you're barely hungry.
Read → PA-C reviewedWhat to Eat on Semaglutide: A Practical Guide to Managing Nausea and Staying Nourished
Nausea on GLP-1 medications is common — but for most people it's temporary and manageable. Here's what the evidence says about what to eat, when to eat it, and when to call your provider.
Read → PA-C reviewedNutrition While Breastfeeding: What Actually Matters
Evidence-based nutrition guidance for breastfeeding and pumping parents — what to eat, what to watch, and what actually affects your milk.
Read → PA-C reviewedWhy Diets Fail: The Psychology Behind the Restrict-Binge Cycle
Understanding the psychological patterns that make restrictive dieting counterproductive for most people.
Read → PA-C reviewedGetting Started with Strength Training
A beginner-friendly framework for building strength — no gym membership required.
Read → PA-C reviewedWhat to Eat on GLP-1 Medications
Practical nutrition guidance for patients taking semaglutide, tirzepatide, or other GLP-1 receptor agonists.
Read → PA-C reviewedMetabolism Explained: What's Actually Happening
What metabolism really is, what affects it, and what the science says about speeding it up.
Read → PA-C reviewedAre You Doomed to Gain Weight After 40?
The real answer about menopause and weight gain — and it's more hopeful than what most people hear.
Read → PA-C reviewedHow Much Protein Do You Actually Need?
The evidence on daily protein targets for weight management — and why the number matters more than most people realize.
Read → PA-C reviewedGLP-1 and Constipation: Why It Happens and What Actually Helps
Coming soon
Why Diets Make You Hungrier: The Physiology of Restriction
Coming soon
GLP-1 Medications and Perimenopause: What the Research Shows
Coming soon